Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|November 9, 2014
Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studiesChris Twelves, Javier Cortes, Linda Vahdat, et al.
Clinical Breast Cancer|July 25, 2008
Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancerCraig Bunnell, Linda Vahdat, Lee Schwartzberg, et al.
Clinical Breast Cancer|July 16, 2014
Phase 2, multicenter, single-arm study of eribulin mesylate with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancerSharon Wilks, Shannon Puhalla, Joyce O'Shaughnessy, et al.
Springerplus|September 29, 2015
Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, single-arm studiesJoyce O'Shaughnessy, Kristi McIntyre, Lee Schwartzberg, et al.
BMC Cancer|June 15, 2019
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancerLee Schwartzberg, Kristi McIntyre, Sharon Wilks, et al.
Breast Cancer (Dove Medical Press)|December 21, 2016
Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter studyShannon Puhalla, Sharon Wilks, Adam M Brufsky, et al.
The Breast Journal|February 27, 2007
The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemmaTara L Huston, Peter I Pressman, Anne Moore, et al.
ACS Nano|August 12, 2025
Customized Nanofibers with Lung-Targeting and -Retention Properties for Treating Isolated Triple-Negative Breast Cancer Pulmonary MetastasesVanessa Bellat, Adam Glaser, Henry Gong, et al.
Advanced Functional Materials|December 4, 2018
Functional Peptide Nanofibers with Unique Tumor Targeting and Enzyme-Induced Local Retention PropertiesVanessa Bellat, Richard Ting, Teresa L Southard, et al.
Clinical Breast Cancer|August 30, 2018
Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical TrialsHope S Rugo, Henri Roche, Eva Thomas, et al.
Pageof 8